Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

British Journal of Haematology

Volumn 148, Issue 5, 2010, Pages 760-767

  Gillmore, Julian D ^a   Tennent, Glenys A ^a   Hutchinson, Winston L ^a   Gallimore, Janet Ruth ^a   Lachmann, Helen J ^a   Goodman, Hugh J B ^a   Offer, Mark ^a   Millar, David J ^a   Petrie, Aviva ^b   Hawkins, Philip N ^a   Pepys, Mark B ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amyloid; Amyloidosis; CPHPC; Depletion; P component

Indexed keywords

1 [6 (2 CARBOXY PYRROLIDIN 1 YL) 6 OXO HEXANOYL]PYRROLIDINE 2 CARBOXYLIC ACID; AMYLOID P COMPONENT; CARBOXYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; DRUG MECHANISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCINTIGRAPHY;

ADULT; AGED; AMYLOIDOSIS; CARBOXYLIC ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; SERUM AMYLOID P-COMPONENT;

EID: 76449109014     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08036.x     Document Type: Article

References (21)

1. Botto, M., Hawkins, P.N., Bickerstaff, M.C.M., Herbert, J., Bygrave, A.E., McBride, A., Hutchinson, W.L., Tennent, G.A., Walport, M.J. Pepys, M.B. (1997) Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Medicine, 3, 855 859.
2. Gertz, M.A., Comenzo, R., Falk, R.H., Fermand, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A. Grateau, G. (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. American Journal of Hematology, 79, 319 328.
3. Gillmore, J.D., Booth, D.R., Rela, M., Heaton, N.D., Rahman, V., Stangou, A.J., Pepys, M.B. Hawkins, P.N. (2000) Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α-chain variant in an English family. Quarterly Journal of Medicine, 93, 269 275.
4. Gillmore, J.D., Lachmann, H.J., Rowczenio, D., Gilbertson, J.A., Zeng, C.-H., Liu, Z.-H., Li, L.-S., Wechalekar, A. Hawkins, P.N. (2009) Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen Aα-chain amyloidosis. Journal of the American Society of Nephrology: JASN, 20, 444 451.
5. 123I-labeled serum amyloid P component. New England Journal of Medicine, 323, 508 513.
6. Hawkins, P.N., Wootton, R. Pepys, M.B. (1990b) Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. Journal of Clinical Investigation, 86, 1862 1869.
7. Hawkins, P.N., Rossor, M.N., Gallimore, J.R., Miller, B., Moore, E.G. Pepys, M.B. (1994) Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease. Biochemical and Biophysical Research Communications, 201, 722 726.
8. Kolstoe, S.E., Ridha, B.H., Bellotti, V., Wang, N., Robinson, C.V., Crutch, S.J., Keir, G., Kukkastenvehmas, R., Gallimore, J.R., Hutchinson, W.L., Hawkins, P.N., Wood, S.P., Rossor, M.N. Pepys, M.B. (2009) Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component. Proceedings of the National Academy of Sciences of the United States of America, 106, 7619 7623.
9. Lachmann, H.J., Gallimore, R., Gillmore, J.D., Carr-Smith, H.D., Bradwell, A.R., Pepys, M.B. Hawkins, P.N. (2003) Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. British Journal of Haematology, 122, 78 84.
10. Lachmann, H.J., Goodman, H.J.B., Gilbertson, J.A., Gallimore, J.R., Sabin, C.A., Gillmore, J.D. Hawkins, P.N. (2007) Natural history and outcome in systemic AA amyloidosis. New England Journal of Medicine, 356, 2361 2371.
11. 2-microglobulin amyloid formation at neutral pH. Biochemistry, 45, 2311 2321.
12. Nelson, S.R., Tennent, G.A., Sethi, D., Gower, P.E., Ballardie, F.W., Amatayakul-Chantler, S. Pepys, M.B. (1991) Serum amyloid P component in chronic renal failure and dialysis. Clinica Chimica Acta: International Journal of Clinical Chemistry, 200, 191.
13. Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T. Carbone, P.P. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649 655.
14. Pepys, M.B. (2006) Amyloidosis. Annual Review of Medicine, 57, 223 241.
15. Pepys, M.B., Dyck, R.F., de Beer, F.C., Skinner, M. Cohen, A.S. (1979) Binding of serum amyloid P component (SAP) by amyloid fibrils. Clinical and Experimental Immunology, 38, 284 293.
16. Pepys, M.B., Booth, D.R., Hutchinson, W.L., Gallimore, J.R., Collins, P.M. Hohenester, E. (1997) Amyloid P component. A critical review. Amyloid: International Journal of Experiment and Clinical Investigation, 4, 274 295.
17. Pepys, M.B., Herbert, J., Hutchinson, W.L., Tennent, G.A., Lachmann, H.J., Gallimore, J.R., Lovat, L.B., Bartfai, T., Alanine, A., Hertel, C., Hoffmann, T., Jakob-Roetne, R., Norcross, R.D., Kemp, J.A., Yamamura, K., Suzuki, M., Taylor, G.W., Murray, S., Thompson, D., Purvis, A., Kolstoe, S., Wood, S.P. Hawkins, P.N. (2002) Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature, 417, 254 259.
18. Puchtler, H., Sweat, F. Levine, M. (1962) On the binding of Congo red by amyloid. Journal of Histochemistry and Cytochemistry, 10, 355 364.
19. Tennent, G.A. (1999) Isolation and characterization of amyloid fibrils from tissue. In : Methods in Enzymology: Amyloid, Prions and Other Protein Aggregates, Vol. 309 (ed. by R. Wetzel pp. 26 47. Academic Press Ltd, San Diego, CA.
20. Tennent, G.A., Lovat, L.B. Pepys, M.B. (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proceedings of the National Academy of Sciences of the United States of America, 92, 4299 4303.
21. Tennent, G.A., Brennan, S.O., Stangou, A.J., O'Grady, J., Hawkins, P.N. Pepys, M.B. (2007) Human plasma fibrinogen is synthesized in the liver. Blood, 109, 1971 1974.